Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Spot Versus Long Lesion Stenting as Best Treatment for Extensive Occlusive SFA Disease; a Pilot Study

NCT03227822 is registered in ClinicalTrials.gov with Catharina Ziekenhuis Eindhoven as lead sponsor.

NCT NCT03227822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03227822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Spot Versus Long Lesion Stenting as Best Treatment for Extensive Occlusive SFA Disease; a Pilot Study
Lead sponsor
Catharina Ziekenhuis Eindhoven
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2013
Completion date
February 1, 2015
Enrollment
3 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease